{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:33:36Z","timestamp":1791977616353,"version":"4.4.0"},"reference-count":124,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation for Youth Scientists of China","doi-asserted-by":"publisher","award":["81703613"],"award-info":[{"award-number":["81703613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2020,1,23]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>An epigenetic effect mainly refers to a heritable modulation in gene expression in the\nshort term but does not involve alterations in the DNA itself. Epigenetic molecular mechanisms\ninclude DNA methylation, histone modification, and untranslated RNA regulation. Antiepileptic\ndrugs have drawn attention to biological and translational medicine because their impact on epigenetic\nmechanisms will lead to the identification of novel biomarkers and possible therapeutic strategies\nfor the prevention and treatment of various diseases ranging from neuropsychological disorders\nto cancers and other chronic conditions. However, these transcriptional and posttranscriptional alterations\ncan also result in adverse reactions and toxicity in vitro and in vivo. Hence, in this review,\nwe focus on recent findings showing epigenetic processes mediated by antiepileptic drugs to elucidate\ntheir application in medical experiments and shed light on epigenetic research for medicinal\npurposes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x17666191010094849","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T08:46:01Z","timestamp":1572338761000},"page":"153-166","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Epigenetic Effects Mediated by Antiepileptic Drugs and their Potential Application"],"prefix":"10.2174","volume":"18","author":[{"given":"Fan-Cheng","family":"Kong","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lai","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Kang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrn1430","volume":"5","author":"Rogawski M.A.","year":"2004","unstructured":"Rogawski M.A.; L\u00f6scher W.; The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004,5(7),553-564","journal-title":"Nat Rev Neurosci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature05913","volume":"447","author":"Bird A.","year":"2007","unstructured":"Bird A.; Perceptions of epigenetics. Nature 2007,447(7143),396-398","journal-title":"Nature"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"Esteller M.","year":"2008","unstructured":"Esteller M.; Epigenetics in cancer. N Engl J Med 2008,358(11),1148-1159","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1470-2045(08)70004-4","volume":"9","author":"Weichert W.","year":"2008","unstructured":"Weichert W.; R\u00f6ske A.; Gekeler V.; Beckers T.; Ebert M.P.; Pross M.; Dietel M.; Denkert C.; R\u00f6cken C.; Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol 2008,9(2),139-148","journal-title":"Lancet Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jpsychires.2010.04.028","volume":"45","author":"Rong H.","year":"2011","unstructured":"Rong H.; Liu T.B.; Yang K.J.; Yang H.C.; Wu D.H.; Liao C.P.; Hong F.; Yang H.Z.; Wan F.; Ye X.Y.; Xu D.; Zhang X.; Chao C.A.; Shen Q.J.; MicroRNA-134 plasma levels before and after treatment for bipolar mania. J Psychiatr Res 2011,45(1),92-95","journal-title":"J Psychiatr Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fonc.2018.00092","volume":"8","author":"Suraweera A.","year":"2018","unstructured":"Suraweera A.; O\u2019Byrne K.J.; Richard D.J.; Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: Achieving the full therapeutic potential of HDACi. Front Oncol 2018,8,92","journal-title":"Front Oncol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"Chou T.C.","year":"1984","unstructured":"Chou T.C.; Talalay P.; Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984,22,27-55","journal-title":"Adv Enzyme Regul"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1037\/a0016301","volume":"13","author":"Masterpasqua F.","year":"2009","unstructured":"Masterpasqua F.; Psychology and Epigenetics. Rev Gen Psychol 2009,13(3),194-201","journal-title":"Rev Gen Psychol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S1474-4422(16)00112-5","volume":"15","author":"Pitk\u00e4nen A.","year":"2016","unstructured":"Pitk\u00e4nen A.; L\u00f6scher W.; Vezzani A.; Becker A.J.; Simonato M.; Lukasiuk K.; Gr\u00f6hn O.; Bankstahl J.P.; Friedman A.; Aronica E.; Gorter J.A.; Ravizza T.; Sisodiya S.M.; Kokaia M.; Beck H.; Advances in the development of biomarkers for epilepsy. Lancet Neurol 2016,15(8),843-856","journal-title":"Lancet Neurol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1158\/1078-0432.CCR-08-2783","volume":"15","author":"Issa J-P.J.","year":"2009","unstructured":"Issa J-P.J.; Kantarjian H.M.; Targeting D.N.A.; Targeting DNA methylation. Clin Cancer Res 2009,15(12),3938-3946","journal-title":"Clin Cancer Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","volume":"26","author":"Xu W.S.","year":"2007","unstructured":"Xu W.S.; Parmigiani R.B.; Marks P.A.; Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007,26(37),5541-5552","journal-title":"Oncogene"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","volume":"45","author":"Eyal S.","year":"2004","unstructured":"Eyal S.; Yagen B.; Sobol E.; Altschuler Y.; Shmuel M.; Bialer M.; The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 2004,45(7),737-744","journal-title":"Epilepsia"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev-pharmtox-061008-103102","volume":"49","author":"Szyf M.","year":"2009","unstructured":"Szyf M.; Epigenetics D.N.A.; Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 2009,49(1),243-263","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=14","first-page":"902","volume":"89","author":"Kacevska M.","year":"2011","unstructured":"Kacevska M.; Ivanov M.; Ingelman\u2010Sundberg M. J. C. P.; Therapeutics, Perspectives on epigenetics and its relevance to adverse drug reactions 2011,89(6),902-907"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/toxsci\/67.1.11","volume":"67","author":"Watson R.E.","year":"2002","unstructured":"Watson R.E.; Goodman J.I.; Epigenetics and DNA methylation come of age in toxicology. Toxicol Sci 2002,67(1),11-16","journal-title":"Toxicol Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"Jones P.A.","year":"2012","unstructured":"Jones P.A.; Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012,13(7),484-492","journal-title":"Nat Rev Genet"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1093\/hmg\/9.16.2395","volume":"9","author":"Bestor T.H.","year":"2000","unstructured":"Bestor T.H.; The DNA methyl transferases of mammals. Hum Mol Genet 2000,9(16),2395-2402","journal-title":"Hum Mol Genet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2007.02.006","volume":"128","author":"Goldberg A.D.","year":"2007","unstructured":"Goldberg A.D.; Allis C.D.; Bernstein E.; Epigenetics: a landscape takes shape. Cell 2007,128(4),635-638","journal-title":"Cell"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.fsigen.2013.05.004","volume":"7","author":"Vidaki A.","year":"2013","unstructured":"Vidaki A.; Daniel B.; Court D.S.; Forensic DNA methylation profiling--potential opportunities and challenges. Forensic Sci Int Genet 2013,7(5),499-507","journal-title":"Forensic Sci Int Genet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mrrev.2018.06.002","volume":"777","author":"Mahna D.","year":"2018","unstructured":"Mahna D.; Puri S.; Sharma S.; DNA methylation signatures: Biomarkers of drug and alcohol abuse. Mutat Res 2018,777,19-28","journal-title":"Mutat Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.4161\/epi.5.8.13053","volume":"5","author":"Dong E.","year":"2010","unstructured":"Dong E.; Chen Y.; Gavin D.P.; Grayson D.R.; Guidotti A.; Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics 2010,5(8),730-735","journal-title":"Epigenetics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/epi.12118","volume":"54","author":"Dezsi G.","year":"2013","unstructured":"Dezsi G.; Ozturk E.; Stanic D.; Powell K.L.; Blumenfeld H.; O\u2019Brien T.J.; Jones N.C.; Ethosuximide reduces epileptogenesis and behavioral comorbidity in the GAERS model of genetic generalized epilepsy. Epilepsia 2013,54(4),635-643","journal-title":"Epilepsia"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.numecd.2013.11.011","volume":"24","author":"Perng W.","year":"2014","unstructured":"Perng W.; Villamor E.; Shroff M.R.; Nettleton J.A.; Pilsner J.R.; Liu Y.; Diez-Roux A.V.; Dietary intake, plasma homocysteine, and repetitive element DNA methylation in the multi-ethnic study of atherosclerosis (MESA). Nutr Metab Cardiovasc Dis 2014,24(6),614-622","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125656","volume":"10","author":"Ni G.","year":"2015","unstructured":"Ni G.; Qin J.; Li H.; Chen Z.; Zhou Y.; Fang Z.; Chen Y.; Zhou J.; Huang M.; Zhou L.; Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy. PLoS One 2015,10(4)","journal-title":"PLoS One"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.clnu.2017.01.004","volume":"37","author":"Ni G.","year":"2018","unstructured":"Ni G.; Qin J.; Chen Z.; Li H.; Zhou J.; Huang M.; Zhou L.; Associations between genetic variation in one-carbon metabolism and leukocyte DNA methylation in valproate-treated patients with epilepsy.  Clin Nutrition, (Edinburgh, Scotland) 2018,37(1),308-312","journal-title":"Clin Nutrition, (Edinburgh, Scotland)"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.fct.2017.05.013","volume":"109","author":"Miousse I.R.","year":"2017","unstructured":"Miousse I.R.; Murphy L.A.; Lin H.; Schisler M.R.; Sun J.; Chalbot M.G.; Sura R.; Johnson K.; LeBaron M.J.; Kavouras I.G.; Schnackenberg L.K.; Beger R.D.; Rasoulpour R.J.; Koturbash I.; Dose-response analysis of epigenetic, metabolic, and apical endpoints after short-term exposure to experimental hepatotoxicants. Food Chem Toxicol 2017,109(Pt 1),690-702","journal-title":"Food Chem Toxicol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00412-009-0221-9","volume":"118","author":"Bogdanovi\u0107 O.","year":"2009","unstructured":"Bogdanovi\u0107 O.; Veenstra G.J.C.; DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009,118(5),549-565","journal-title":"Chromosoma"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/bph.12309","volume":"170","author":"Pucci M.","year":"2013","unstructured":"Pucci M.; Rapino C.; Di Francesco A.; Dainese E.; D\u2019Addario C.; Maccarrone M.; Epigenetic control of skin differentiation genes by phytocannabinoids. Br J Pharmacol 2013,170(3),581-591","journal-title":"Br J Pharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1021\/cb500846u","volume":"10","author":"Fan J.","year":"2015","unstructured":"Fan J.; Krautkramer K.A.; Feldman J.L.; Denu J.M.; Metabolic regulation of histone post-translational modifications. ACS Chem Biol 2015,10(1),95-108","journal-title":"ACS Chem Biol"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"Seto E.","year":"2014","unstructured":"Seto E.; Yoshida M.; Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol 2014,6(4)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"G\u00f6ttlicher M.","year":"2001","unstructured":"G\u00f6ttlicher M.; Minucci S.; Zhu P.; Kr\u00e4mer O.H.; Schimpf A.; Giavara S.; Sleeman J.P.; Lo Coco F.; Nervi C.; Pelicci P.G.; Heinzel T.; Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001,20(24),6969-6978","journal-title":"EMBO J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.lfs.2005.01.003","volume":"76","author":"Beutler A.S.","year":"2005","unstructured":"Beutler A.S.; Li S.; Nicol R.; Walsh M.J.; Carbamazepine is an inhibitor of histone deacetylases. Life Sci 2005,76(26),3107-3115","journal-title":"Life Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pbb.2015.04.011","volume":"134","author":"Bang S.R.","year":"2015","unstructured":"Bang S.R.; Ambavade S.D.; Jagdale P.G.; Adkar P.P.; Waghmare A.B.; Ambavade P.D.; Lacosamide reduces HDAC levels in the brain and improves memory: Potential for treatment of Alzheimer\u2019s disease. Pharmacol Biochem Behav 2015,134,65-69","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.0013-9580.2004.00104.x","volume":"45","author":"Eyal S.","year":"2004","unstructured":"Eyal S.; Yagen B.; Sobol E.; Altschuler Y.; Shmuel M.; Bialer M.; The activity of antiepileptic drugs as histone deacetylase inhibitors. Epilepsia 2004,45(7),737-744","journal-title":"Epilepsia"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2016.117","volume":"16","author":"Matsui M.","year":"2017","unstructured":"Matsui M.; Corey D.R.; Non-coding RNAs as drug targets. Nat Rev Drug Discov 2017,16(3),167-179","journal-title":"Nat Rev Drug Discov"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1111\/epi.13915","volume":"58","author":"van Vliet E.A.","year":"2017","unstructured":"van Vliet E.A.; Puhakka N.; Mills J.D.; Srivastava P.K.; Johnson M.R.; Roncon P.; Das Gupta S.; Karttunen J.; Simonato M.; Lukasiuk K.; Gorter J.A.; Aronica E.; Pitk\u00e4nen A.; Standardization procedure for plasma biomarker analysis in rat models of epileptogenesis: Focus on circulating microRNAs. Epilepsia 2017,58(12),2013-2024","journal-title":"Epilepsia"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.drudis.2012.10.002","volume":"18","author":"Pereira D.M.","year":"2013","unstructured":"Pereira D.M.; Rodrigues P.M.; Borralho P.M.; Rodrigues C.M.P.; Delivering the promise of miRNA cancer therapeutics. Drug Discov Today 2013,18(5-6),282-289","journal-title":"Drug Discov Today"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003420","volume":"3","author":"Lu M.","year":"2008","unstructured":"Lu M.; Zhang Q.; Deng M.; Miao J.; Guo Y.; Gao W.; Cui Q.; An analysis of human microRNA and disease associations. PLoS One 2008,3(10)","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuint.2015.10.010","volume":"91","author":"Oikawa H.","year":"2015","unstructured":"Oikawa H.; Goh W.W.; Lim V.K.; Wong L.; Sng J.C.; Valproic acid mediates miR-124 to down-regulate a novel protein target, GNAI1. Neurochem Int 2015,91,62-71","journal-title":"Neurochem Int"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13046-019-1160-9","volume":"38","author":"Lin T.","year":"2019","unstructured":"Lin T.; Ren Q.; Zuo W.; Jia R.; Xie L.; Lin R.; Zhao H.; Chen J.; Lei Y.; Wang P.; Dong H.; Huang L.; Cai J.; Peng Y.; Yu Z.; Tan J.; Wang S.; Valproic acid exhibits anti-tumor activity selectively against EGFR\/ErbB2\/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs. J Exp Clin Cancer Res 2019,38(1),150","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13229-017-0149-5","volume":"8","author":"Hara Y.","year":"2017","unstructured":"Hara Y.; Ago Y.; Takano E.; Hasebe S.; Nakazawa T.; Hashimoto H.; Matsuda T.; Takuma K.; Prenatal exposure to valproic acid increases miR-132 levels in the mouse embryonic brain. Mol Autism 2017,8,33","journal-title":"Mol Autism"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/toxsci\/kfx104","volume":"158","author":"Pouche L.","year":"2017","unstructured":"Pouche L.; Vitobello A.; Romer M.; Glogovac M.; MacLeod A.K.; Ellinger-Ziegelbauer H.; Westphal M.; Dubost V.; Stiehl D.P.; Dumotier B.; Fekete A.; Moulin P.; Zell A.; Schwarz M.; Moreno R.; Huang J.T.J.; Elcombe C.R.; Henderson C.J.; Roland Wolf C.; Moggs J.G.; Terranova R.; Xenobiotic CAR Activators induce Dlk1-Dio3 locus noncoding RNA expression in mouse liver. Toxicol Sci 2017,158(2),367-378","journal-title":"Toxicol Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1021\/acs.chemrestox.7b00330","volume":"31","author":"Monroy-Arreola A.","year":"2018","unstructured":"Monroy-Arreola A.; Dur\u00e1n-Figueroa N.V.; M\u00e9ndez-Flores S.; Dom\u00ednguez-Cherit J.; Watkinson J.; Badillo-Corona J.A.; Whitaker P.; Naisbitt D.J.; Castrej\u00f3n-Flores J.L.; Up-Regulation of T-cell activation microRNAs in drug-specific CD4 T-cells from Hypersensitive patients. Chem Res Toxicol 2018,31(6),454-461","journal-title":"Chem Res Toxicol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nbd.2016.12.007","volume":"99","author":"Iori V.","year":"2017","unstructured":"Iori V.; Iyer A.M.; Ravizza T.; Beltrame L.; Paracchini L.; Marchini S.; Cerovic M.; Hill C.; Ferrari M.; Zucchetti M.; Molteni M.; Rossetti C.; Brambilla R.; Steve W.H.; D\u2019Incalci M.; Aronica E.; Vezzani A.; Blockade of the IL-1R1\/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy. Neurobiol Dis 2017,99,12-23","journal-title":"Neurobiol Dis"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1159\/000489111","volume":"46","author":"Xu M.","year":"2018","unstructured":"Xu M.; Li D.; Yang C.; Ji J.S.; MicroRNA-34a Inhibition of the TLR signaling pathway Via CXCL10 suppresses breast cancer Cell invasion and migration. Cell Physiol Biochem 2018,46(3),1286-1304","journal-title":"Cell Physiol Biochem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.2174\/0929867311320290004","volume":"20","author":"Cheng C.J.","year":"2013","unstructured":"Cheng C.J.; Saltzman W.M.; Slack F.J.; Canonical and non-canonical barriers facing antimiR cancer therapeutics. Curr Med Chem 2013,20(29),3582-3593","journal-title":"Curr Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","volume":"51","author":"Ngugi A.K.","year":"2010","unstructured":"Ngugi A.K.; Bottomley C.; Kleinschmidt I.; Sander J.W.; Newton C.R.; Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010,51(5),883-890","journal-title":"Epilepsia"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1056\/NEJM200002033420503","volume":"342","author":"Kwan P.","year":"2000","unstructured":"Kwan P.; Brodie M.J.; Early identification of refractory epilepsy. N Engl J Med 2000,342(5),314-319","journal-title":"N Engl J Med"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S1474-4422(16)00112-5","volume":"15","author":"Pitk\u00e4nen A.","year":"2016","unstructured":"Pitk\u00e4nen A.; L\u00f6scher W.; Vezzani A.; Becker A.J.; Simonato M.; Lukasiuk K.; Gr\u00f6hn O.; Bankstahl J.P.; Friedman A.; Aronica E.; Gorter J.A.; Ravizza T.; Sisodiya S.M.; Kokaia M.; Beck H.; Advances in the development of biomarkers for epilepsy. Lancet Neurol 2016,15(8),843-856","journal-title":"Lancet Neurol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nbd.2013.08.015","volume":"60","author":"Grimminger T.","year":"2013","unstructured":"Grimminger T.; Pernhorst K.; Surges R.; Niehusmann P.; Priebe L.; von Lehe M.; Hoffmann P.; Cichon S.; Schoch S.; Becker A.J.; Levetiracetam resistance: Synaptic signatures","journal-title":"Neurobiol Dis"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1007\/s12035-019-1565-7","volume":"56","author":"You D.","year":"2019","unstructured":"You D.; Wen X.; Gorczyca L.; Morris A.; Richardson J.R.; Aleksunes L.M.; Increased MDR1 transporter expression in human brain endothelial cells through enhanced histone acetylation and activation of aryl hydrocarbon receptor signaling. Mol Neurobiol 2019,56(10),6986-7002","journal-title":"Mol Neurobiol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s12035-016-9871-9","volume":"54","author":"Tan N.N.","year":"2017","unstructured":"Tan N.N.; Tang H.L.; Lin G.W.; Chen Y.H.; Lu P.; Li H.J.; Gao M.M.; Zhao Q.H.; Yi Y.H.; Liao W.P.; Long Y.S.; Epigenetic downregulation of Scn3a expression by valproate: A possible role in its anticonvulsant activity. Mol Neurobiol 2017,54(4),2831-2842","journal-title":"Mol Neurobiol"},{"key":"ref=53","first-page":"37","volume":"16","author":"Ma Y.","year":"2018","unstructured":"Ma Y.; The Challenge of microRNA as a biomarker of epilepsy. Curr Neuropharmacol 2018,16(1),37-42","journal-title":"Curr Neuropharmacol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1111\/epi.14557","volume":"59","author":"Bialer M.","year":"2018","unstructured":"Bialer M.; Johannessen S.I.; Koepp M.J.; Levy R.H.; Perucca E.; Tomson T.; White H.S.; Progress report on new antiepileptic drugs: A summary of the fourteenth eilat conference on new antiepileptic drugs and devices (EILAT XIV). I. Drugs in preclinical and early clinical development. Epilepsia 2018,59(10),1811-1841","journal-title":"Epilepsia"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrd2133","volume":"5","author":"Bolden J.E.","year":"2006","unstructured":"Bolden J.E.; Peart M.J.; Johnstone R.W.; Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006,5(9),769-784","journal-title":"Nat Rev Drug Discov"},{"key":"ref=56","first-page":"545","volume":"10","author":"Sun L.","year":"2018","unstructured":"Sun L.; He Q.; Tsai C.; Lei J.; Chen J.; Vienna M.L.; Coy D.H.; HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II. Am J Transl Res 2018,10(2),545-553","journal-title":"Am J Transl Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1159\/000485753","volume":"44","author":"Eckert M.","year":"2017","unstructured":"Eckert M.; Klumpp L.; Huber S.M.; Cellular effects of the antiepileptic drug valproic acid in glioblastoma. Cell Physiol Biochem 2017,44(4),1591-1605","journal-title":"Cell Physiol Biochem"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cbi.2017.12.003","volume":"280","author":"Aztopal N.","year":"2018","unstructured":"Aztopal N.; Erkisa M.; Erturk E.; Ulukaya E.; Tokullugil A.H.; Ari F.; Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells. Chem Biol Interact 2018,280,51-58","journal-title":"Chem Biol Interact"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13046-018-0978-x","volume":"37","author":"La Noce M.","year":"2018","unstructured":"La Noce M.; Paino F.; Mele L.; Papaccio G.; Regad T.; Lombardi A.; Papaccio F.; Desiderio V.; Tirino V.; HDAC2 depletion promotes osteosarcoma\u2019s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy. J Exp Clin Cancer Res 2018,37(1),296","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13046-017-0647-5","volume":"36","author":"Terranova-Barberio M.","year":"2017","unstructured":"Terranova-Barberio M.; Pecori B.; Roca M.S.; Imbimbo S.; Bruzzese F.; Leone A.; Muto P.; Delrio P.; Avallone A.; Budillon A.; Di Gennaro E.; Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53. J Exp Clin Cancer Res 2017,36(1),177","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13148-017-0359-x","volume":"9","author":"Halaburkov\u00e1 A.","year":"2017","unstructured":"Halaburkov\u00e1 A.; Jend\u017eelovsk\u00fd R.; Kova\u013e J.; Herceg Z.; Fedoro\u010dko P.; Ghantous A.; Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A. Clin Epigenetics 2017,9,62","journal-title":"Clin Epigenetics"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2015.12.016","volume":"372","author":"Cha H.Y.","year":"2016","unstructured":"Cha H.Y.; Lee B.S.; Chang J.W.; Park J.K.; Han J.H.; Kim Y.S.; Shin Y.S.; Byeon H.K.; Kim C.H.; Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL. Cancer Lett 2016,372(1),65-74","journal-title":"Cancer Lett"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040566","volume":"11","author":"Makarevi\u0107 J.","year":"2019","unstructured":"Makarevi\u0107 J.; Rutz J.; Juengel E.; Maxeiner S.; Tsaur I.; Chun F.K.; Bereiter-Hahn J.; Blaheta R.A.; Influence of the HDAC Inhibitor valproic Acid on the growth and proliferation of temsirolimus-resistant prostate cancer cells In Vitro. Cancers (Basel) 2019,11(4)","journal-title":"Cancers (Basel)"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s12010-017-2684-0","volume":"185","author":"Sajadpoor Z.","year":"2018","unstructured":"Sajadpoor Z.; Amini-Farsani Z.; Teimori H.; Shamsara M.; Sangtarash M.H.; Ghasemi-Dehkordi P.; Yadollahi F.; Valproic acid promotes apoptosis and cisplatin sensitivity through downregulation of H19 noncoding RNA in ovarian A2780 cells. Appl Biochem Biotechnol 2018,185(4),1132-1144","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=65","first-page":"2202","volume":"5","author":"Zhuo W.","year":"2015","unstructured":"Zhuo W.; Zhang L.; Zhu Y.; Xie Q.; Zhu B.; Chen Z.; Valproic acid, an inhibitor of class I histone deacetylases, reverses acquired Erlotinib-resistance of lung adenocarcinoma cells: A connectivity Mapping analysis and an experimental study. Am J Cancer Res 2015,5(7),2202-2211","journal-title":"Am J Cancer Res"},{"key":"ref=66","first-page":"1299","volume":"7","author":"Matsuda Y.","year":"2014","unstructured":"Matsuda Y.; Wakai T.; Kubota M.; Osawa M.; Hirose Y.; Sakata J.; Kobayashi T.; Fujimaki S.; Takamura M.; Yamagiwa S.; Aoyagi Y.; Valproic acid overcomes transforming growth factor-\u03b2-mediated sorafenib resistance in hepatocellular carcinoma. Int J Clin Exp Pathol 2014,7(4),1299-1313","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11523-015-0370-0","volume":"10","author":"Wang Y.","year":"2015","unstructured":"Wang Y.; Kuramitsu Y.; Kitagawa T.; Tokuda K.; Baron B.; Akada J.; Nakamura K.; The histone deacetylase inhibitor Valproic acid sensitizes gemcitabine-Induced Cytotoxicity in Gemcitabine-resistant pancreatic cancer cells possibly through inhibition of the DNA repair protein gamma-H2AX. Target Oncol 2015,10(4),575-581","journal-title":"Target Oncol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1038\/sj.bjc.6603777","volume":"96","author":"Blaheta R.A.","year":"2007","unstructured":"Blaheta R.A.; Michaelis M.; Natsheh I.; Hasenberg C.; Weich E.; Relja B.; Jonas D.; Doerr H.W.; Cinatl J.; Jr Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium. Br J Cancer 2007,96(11),1699-1706","journal-title":"Br J Cancer"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/cncr.29439","volume":"121","author":"Kim Y.H.","year":"2015","unstructured":"Kim Y.H.; Kim T.; Joo J.D.; Han J.H.; Kim Y.J.; Kim I.A.; Yun C.H.; Kim C.Y.; Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme. Cancer 2015,121(17),2926-2932","journal-title":"Cancer"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12935-018-0626-8","volume":"18","author":"Scicchitano B.M.","year":"2018","unstructured":"Scicchitano B.M.; Sorrentino S.; Proietti G.; Lama G.; Dobrowolny G.; Catizone A.; Binda E.; Larocca L.M.; Sica G.; Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis. Cancer Cell Int 2018,18(1),136","journal-title":"Cancer Cell Int"},{"key":"ref=71","first-page":"76","volume":"36","author":"Rizzo A.","year":"2017","unstructured":"Rizzo A.; Donzelli S.; Girgenti V.; Sacconi A.; Vasco C.; Salmaggi A.; Blandino G.; Maschio M.; Ciusani E.; \n                        In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells. Journal of experimental","journal-title":"CR (East Lansing Mich)"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-017-0655-2","volume":"16","author":"Bellissimo T.","year":"2017","unstructured":"Bellissimo T.; Ganci F.; Gallo E.; Sacconi A.; Tito C.; De Angelis L.; Pulito C.; Masciarelli S.; Diso D.; Anile M.; Petrozza V.; Giangaspero F.; Pescarmona E.; Facciolo F.; Venuta F.; Marino M.; Blandino G.; Fazi F.; Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation. Mol Cancer 2017,16(1),88","journal-title":"Mol Cancer"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/epd.2009.0238","volume":"11","author":"Mula M.","year":"2009","unstructured":"Mula M.; Monaco F. J. E. D.; Antiepileptic drugs and psychopathology of epilepsy: an update. 2009,11(1),1-9"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.2042-7158.2012.01475.x","volume":"64","author":"Boyadjieva N.","year":"2012","unstructured":"Boyadjieva N.; Varadinova M.; Epigenetics of psychoactive drugs. J Pharm Pharmacol 2012,64(10),1349-1358","journal-title":"J Pharm Pharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/sj.mp.4001885","volume":"11","author":"Severinsen J.E.","year":"2006","unstructured":"Severinsen J.E.; Bjarkam C.R.; Kiaer-Larsen S.; Olsen I.M.; Nielsen M.M.; Blechingberg J.; Nielsen A.L.; Holm I.E.; Foldager L.; Young B.D.; Muir W.J.; Blackwood D.H.; Corydon T.J.; Mors O.; B\u00f8rglum A.D.; Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder. Mol Psychiatry 2006,11(12),1126-1138","journal-title":"Mol Psychiatry"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170121","volume":"12","author":"Dyrvig M.","year":"2017","unstructured":"Dyrvig M.; Qvist P.; Lichota J.; Larsen K.; Nyegaard M.; B\u00f8rglum A.D.; Christensen J.H.; DNA Methylation Analysis of BRD1 Promoter Regions and the Schizophrenia rs138880 Risk Allele. PLoS One 2017,12(1)","journal-title":"PLoS One"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jpsychires.2016.12.019","volume":"88","author":"Zong L.","year":"2017","unstructured":"Zong L.; Zhou L.; Hou Y.; Zhang L.; Jiang W.; Zhang W.; Wang L.; Luo X.; Wang S.; Deng C.; Peng Z.; Li S.; Hu J.; Zhao H.; Zhao C.; Genetic and epigenetic regulation on the transcription of GABRB2: Genotype-dependent hydroxymethylation and methylation alterations in schizophrenia. J Psychiatr Res 2017,88,9-17","journal-title":"J Psychiatr Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuropharm.2018.11.035","volume":"146","author":"Stark T.","year":"2019","unstructured":"Stark T.; Ruda-Kucerova J.; Iannotti F.A.; D\u2019Addario C.; Di Marco R.; Pekarik V.; Drazanova E.; Piscitelli F.; Bari M.; Babinska Z.; Giurdanella G.; Di Bartolomeo M.; Salomone S.; Sulcova A.; Maccarrone M.; Wotjak C.T.; Starcuk Z.; Drago F.; Mechoulam R.; Di Marzo V.; Micale V.; Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia. Neuropharmacology 2019,146,212-221","journal-title":"Neuropharmacology"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jpsychires.2013.05.028","volume":"47","author":"Ookubo M.","year":"2013","unstructured":"Ookubo M.; Kanai H.; Aoki H.; Yamada N.; Antidepressants and mood stabilizers effects on histone deacetylase expression in C57BL\/6 mice: Brain region specific changes. J Psychiatr Res 2013,47(9),1204-1214","journal-title":"J Psychiatr Res"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.euroneuro.2017.06.002","volume":"27","author":"Bahna S.G.","year":"2017","unstructured":"Bahna S.G.; Niles L.P.; Epigenetic induction of melatonin MT1 receptors by valproate: Neurotherapeutic implications. Eur Neuropsychopharmacol 2017,27(8),828-832","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2217\/epi.15.98","volume":"8","author":"Houtepen L.C.","year":"2016","unstructured":"Houtepen L.C.; van Bergen A.H.; Vinkers C.H.; Boks M.P.; DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder. Epigenomics 2016,8(2),197-208","journal-title":"Epigenomics"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/TA.0000000000002119","volume":"86","author":"Nikolian V.C.","year":"2018","unstructured":"Nikolian V.C.; Dennahy I.S.; Weykamp M.; Williams A.M.; Bhatti U.F.; Eidy H.; Ghandour M.; Chtraklin K.; Li Y.; Alam H.B.; Isoform 6-selective histone deacetylase inhibition reduces lesion size and brain swelling following traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg 2018,86(2),232-239","journal-title":"J Trauma Acute Care Surg"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/ijnp\/pyw035","volume":"19","author":"Leng Y.","year":"2016","unstructured":"Leng Y.; Wang J.; Wang Z.; Liao H.M.; Wei M.; Leeds P.; Chuang D.M.; Valproic acid and other HDAC Inhibitors upregulate FGF21 gene expression and promote process elongation in glia by inhibiting HDAC2 and 3. Int J Neuropsychopharmacol 2016,19(8),13","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.01.014","volume":"139","author":"da Silva V.K.","year":"2018","unstructured":"da Silva V.K.; de Freitas B.S.; Dornelles V.C.; Kist L.W.; Bogo M.R.; Silva M.C.; Streck E.L.; Hallak J.E.; Zuardi A.W.; Crippa J.A.S.; Schr\u00f6der N.; Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration: Reversal by cannabidiol. Brain Res Bull 2018,139,1-8","journal-title":"Brain Res Bull"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuropharm.2017.07.020","volume":"125","author":"Green A.L.","year":"2017","unstructured":"Green A.L.; Zhan L.; Eid A.; Zarbl H.; Guo G.L.; Richardson J.R.; Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1. Neuropharmacology 2017,125,189-196","journal-title":"Neuropharmacology"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.47.3.626","volume":"47","author":"Armon C.","year":"1996","unstructured":"Armon C.; Shin C.; Miller P.; Carwile S.; Brown E.; Edinger J.D.; Paul R.G.; Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 1996,47(3),626-635","journal-title":"Neurology"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/928326","author":"Kee H.J.","year":"2011","unstructured":"Kee H.J.; Kook H.; Roles and targets of class I and IIa histone deacetylases in cardiac hypertrophy. J Biomed Biotechnol 2011","journal-title":"J Biomed Biotechnol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","volume":"52","author":"McKinsey T.A.","year":"2012","unstructured":"McKinsey T.A.; Therapeutic potential for HDAC inhibitors in the heart. Annu Rev Pharmacol Toxicol 2012,52,303-319","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/STROKEAHA.114.007213","volume":"46","author":"Azghandi S.","year":"2015","unstructured":"Azghandi S.; Prell C.; van der Laan S.W.; Schneider M.; Malik R.; Berer K.; Gerdes N.; Pasterkamp G.; Weber C.; Haffner C.; Dichgans M.; Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1. Stroke 2015,46(1),197-202","journal-title":"Stroke"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/STROKEAHA.117.016674","volume":"49","author":"Brookes R.L.","year":"2018","unstructured":"Brookes R.L.; Crichton S.; Wolfe C.D.A.; Yi Q.; Li L.; Hankey G.J.; Rothwell P.M.; Markus H.S.; Sodium valproate, a histone deacetylasei, is associated with reduced stroke risk after previous ischemic stroke or transient ischemic attack. Stroke 2018,49(1),54-61","journal-title":"Stroke"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1038\/ijo.2017.166","volume":"41","author":"Choi J.","year":"2017","unstructured":"Choi J.; Park S.; Kwon T. K.; Sohn S. I.; Park K. M.; Kim J. I.; Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1\/angiotensin II axis Intl. J Obesity (2005) 2017,41(11),1702-1709","journal-title":"J Obesity (2005)"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.007071","volume":"12","author":"Scholz B.","year":"2019","unstructured":"Scholz B.; Schulte J.S.; Hamer S.; Himmler K.; Pluteanu F.; Seidl M.D.; Stein J.; Wardelmann E.; Hammer E.; V\u00f6lker U.; M\u00fcller F.U.; HDAC (Histone deacetylase) inhibitor valproic acid attenuates atrial remodeling and delays the onset of atrial fibrillation in mice. Circ Arrhythm Electrophysiol 2019,12(3)","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113539","volume":"19","author":"Cho H.M.","year":"2018","unstructured":"Cho H.M.; Seok Y.M.; Lee H.A.; Song M.; Kim I.; Repression of transcriptional activity of forkhead Box O1 by histone deacetylase inhibitors ameliorates hyperglycemia in Type 2 diabetic rats. Int J Mol Sci 2018,19(11)","journal-title":"Int J Mol Sci"},{"key":"ref=94","first-page":"95","volume":"41","author":"Nguy\u1ec5n-Thanh T.","year":"2018","unstructured":"Nguy\u1ec5n-Thanh T.; Kim D.; Lee S.; Kim W.; Park S.K.; Kang K.P.; Inhibition of histone deacetylase 1 ameliorates renal tubulointerstitial fibrosis via modulation of inflammation and extracellular matrix gene transcription in mice. Int J Mol Med 2018,41(1),95-106","journal-title":"Int J Mol Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrm2727","volume":"10","author":"Hemberger M.","year":"2009","unstructured":"Hemberger M.; Dean W.; Reik W.; Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington\u2019s canal. Nat Rev Mol Cell Biol 2009,10(8),526-537","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"16659","DOI":"10.1073\/pnas.0407643101","volume":"101","author":"Hsieh J.","year":"2004","unstructured":"Hsieh J.; Nakashima K.; Kuwabara T.; Mejia E.; Gage F.H.; Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 2004,101(47),16659-16664","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.stemcr.2017.04.006","volume":"8","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; He X.; Li Q.; Kong X.; Ou Z.; Zhang L.; Gong Z.; Long D.; Li J.; Zhang M.; Ji W.; Zhang W.; Xu L.; Xuan A.; PI3K\/AKT\/mTOR Signaling mediates valproic Acid-Induced neuronal differentiation of neural stem cells through epigenetic modifications. Stem Cell Reports 2017,8(5),1256-1269","journal-title":"Stem Cell Reports"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/mp.2015.3","volume":"20","author":"Vuki\u0107evi\u0107 V.","year":"2015","unstructured":"Vuki\u0107evi\u0107 V.; Qin N.; Balyura M.; Eisenhofer G.; Wong M.L.; Licinio J.; Bornstein S.R.; Ehrhart-Bornstein M.; Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells. Mol Psychiatry 2015,20(8),941-950","journal-title":"Mol Psychiatry"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.biomaterials.2018.03.043","volume":"172","author":"Zhang C.","year":"2018","unstructured":"Zhang C.; Zhang E.; Yang L.; Tu W.; Lin J.; Yuan C.; Bunpetch V.; Chen X.; Ouyang H.; Histone deacetylase inhibitor treated cell sheet from mouse tendon stem\/progenitor cells promotes tendon repair. Biomaterials 2018,172,66-82","journal-title":"Biomaterials"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.nbd.2017.05.010","volume":"105","author":"Jamal I.","year":"2017","unstructured":"Jamal I.; Kumar V.; Vatsa N.; Shekhar S.; Singh B.K.; Sharma A.; Jana N.R.; Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome. Neurobiol Dis 2017,105,99-108","journal-title":"Neurobiol Dis"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12974-018-1193-6","volume":"15","author":"Chen S.","year":"2018","unstructured":"Chen S.; Ye J.; Chen X.; Shi J.; Wu W.; Lin W.; Lin W.; Li Y.; Fu H.; Li S.; Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3. J Neuroinflammation 2018,15(1),150","journal-title":"J Neuroinflammation"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.yexcr.2016.03.015","volume":"343","author":"Raut A.","year":"2016","unstructured":"Raut A.; Khanna A.; Enhanced expression of hepatocyte-specific microRNAs in valproic acid mediated hepatic trans-differentiation of human umbilical cord derived mesenchymal stem cells. Exp Cell Res 2016,343(2),237-247","journal-title":"Exp Cell Res"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.fct.2017.09.014","volume":"109","author":"Ideta-Otsuka M.","year":"2017","unstructured":"Ideta-Otsuka M.; Igarashi K.; Narita M.; Hirabayashi Y.; Epigenetic toxicity of environmental chemicals upon exposure during development - Bisphenol A and valproic acid may have epigenetic effects. Food Chem Toxicol 2017,109(Pt 1),812-816","journal-title":"Food Chem Toxicol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/10408444.2016.1175417","volume":"46","author":"Marczylo E.L.","year":"2016","unstructured":"Marczylo E.L.; Jacobs M.N.; Gant T.W.; Environmentally induced epigenetic toxicity: potential public health concerns. Crit Rev Toxicol 2016,46(8),676-700","journal-title":"Crit Rev Toxicol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1093\/carcin\/bgt212","volume":"34","author":"Herceg Z.","year":"2013","unstructured":"Herceg Z.; Lambert M-P.; van Veldhoven K.; Demetriou C.; Vineis P.; Smith M.T.; Straif K.; Wild C.P.; Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis 2013,34(9),1955-1967","journal-title":"Carcinogenesis"},{"key":"ref=106","first-page":"i","volume":"79","year":"2001","unstructured":"Some thyrotropic agents. IARC Monogr Eval Carcinog Risks Hum 2001,79,i-iv, 1-725","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/toxsci\/kfj001","volume":"89","author":"Holsapple M.P.","year":"2006","unstructured":"Holsapple M.P.; Pitot H.C.; Cohen S.M.; Boobis A.R.; Klaunig J.E.; Pastoor T.; Dellarco V.L.; Dragan Y.P.; Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci 2006,89(1),51-56","journal-title":"Toxicol Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1474-4422(12)70103-5","volume":"11","author":"Tomson T.","year":"2012","unstructured":"Tomson T.; Battino D.; Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012,11(9),803-813","journal-title":"Lancet Neurol"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/WNL.42.1.32","volume":"42","author":"Dansky L.","year":"1992","unstructured":"Dansky L.; Rosenblatt D.; Andermann E.J.N.; Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992,42(4)(Suppl. 5),32-42","journal-title":"Neurology"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s00415-018-9058-6","volume":"265","author":"Al-Ansari A.","year":"2018","unstructured":"Al-Ansari A.; Robertson N.P.; Anti-epileptics and pregnancy: an update. J Neurol 2018,265(11),2749-2751","journal-title":"J Neurol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.070466","volume":"47","author":"Mart\u00ednez-Fr\u00edas M.L.","year":"2010","unstructured":"Mart\u00ednez-Fr\u00edas M.L.; Can our understanding of epigenetics assist with primary prevention of congenital defects? J Med Genet 2010,47(2),73-80","journal-title":"J Med Genet"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.taap.2010.08.001","volume":"248","author":"Tung E.W.","year":"2010","unstructured":"Tung E.W.; Winn L.M.; Epigenetic modifications in valproic acid-induced teratogenesis. Toxicol Appl Pharmacol 2010,248(3),201-209","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"229","author":"Nicolini C.","year":"2018","unstructured":"Nicolini C.; Fahnestock M.; The valproic acid-induced rodent model of autism. Exper Neurol 2018,229(Pt A),217-227","journal-title":"Exper Neurol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.fct.2018.02.061","volume":"115","author":"Hirsch M.M.","year":"2018","unstructured":"Hirsch M.M.; Deckmann I.; Fontes-Dutra M.; Bauer-Negrini G.; Della-Flora Nunes G.; Nunes W.; Rabelo B.; Riesgo R.; Margis R.; Bambini-Junior V.; Gottfried C.; Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA. Food Chemical Toxicol 2018,115,336-343","journal-title":"Food Chemical Toxicol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s13105-016-0532-2","volume":"73","author":"Yadav S.","year":"2017","unstructured":"Yadav S.; Tiwari V.; Singh M.; Yadav R.K.; Roy S.; Devi U.; Gautam S.; Rawat J.K.; Ansari M.N.; Saeedan A.S.; Prakash A.; Saraf S.A.; Kaithwas G.; Comparative efficacy of alpha-linolenic acid and gamma-linolenic acid to attenuate valproic acid-induced autism-like features. J Physiol Biochem 2017,73(2),187-198","journal-title":"J Physiol Biochem"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12012-015-9316-0","volume":"16","author":"Yu W.H.","year":"2016","unstructured":"Yu W.H.; Ho Y.L.; Huang P.T.; Chu S.L.; Tsai H.J.; Liou H.H.; The phosphorylation state of GSK3\u03b2 serine 9 correlated to the Development of valproic acid-associated fetal cardiac teratogenicity, fetal VPA syndrome, rescued by folic acid administration. Cardiovasc Toxicol 2016,16(1),34-45","journal-title":"Cardiovasc Toxicol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tox.2017.11.013","volume":"393","author":"van Breda S.G.J.","year":"2018","unstructured":"van Breda S.G.J.; Claessen S.M.H.; van Herwijnen M.; Theunissen D.H.J.; Jennen D.G.J.; de Kok T.M.C.M.; Kleinjans J.C.S.; Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology 2018,393,160-170","journal-title":"Toxicology"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.exer.2014.01.021","volume":"121","author":"Palsamy P.","year":"2014","unstructured":"Palsamy P.; Bidasee K.R.; Shinohara T.; Valproic acid suppresses Nrf2\/Keap1 dependent antioxidant protection through induction of endoplasmic reticulum stress and Keap1 promoter DNA demethylation in human lens epithelial cells. Exp Eye Res 2014,121,26-34","journal-title":"Exp Eye Res"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1016\/j.ajpath.2015.08.006","volume":"185","author":"Eisses J.F.","year":"2015","unstructured":"Eisses J.F.; Criscimanna A.; Dionise Z.R.; Orabi A.I.; Javed T.A.; Sarwar S.; Jin S.; Zhou L.; Singh S.; Poddar M.; Davis A.W.; Tosun A.B.; Ozolek J.A.; Lowe M.E.; Monga S.P.; Rohde G.K.; Esni F.; Husain S.Z.; Valproic acid Limits pancreatic recovery after pancreatitis by inhibiting histone deacetylases and preventing acinar redifferentiation Programs. Am J Pathol 2015,185(12),3304-3315","journal-title":"Am J Pathol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1124\/dmd.115.067439","volume":"44","author":"Sakakibara Y.","year":"2016","unstructured":"Sakakibara Y.; Katoh M.; Kondo Y.; Nadai M.; Effects of phenobarbital on expression of UDP-Glucuronosyltransferase 1a6 and 1a7 in rat brain. Drug Metab Dispos 2016,44(3),370-377","journal-title":"Drug Metab Dispos"},{"key":"ref=121","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.552","volume":"8","author":"Ma T.","year":"2017","unstructured":"Ma T.; Huang C.; Xu Q.; Yang Y.; Liu Y.; Meng X.; Li J.; Ye M.; Liang H.; Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury. Cell Death Dis 2017,8(10)","journal-title":"Cell Death Dis"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.phrs.2016.03.028","volume":"107","author":"Anderson S.J.","year":"2016","unstructured":"Anderson S.J.; Feye K.M.; Schmidt-McCormack G.R.; Malovic E.; Mlynarczyk G.S.A.; Izbicki P.; Arnold L.F.; Jefferson M.A.; de la Rosa B.M.; Wehrman R.F.; Luna K.C.; Hu H.Z.; Kondru N.C.; Kleinhenz M.D.; Smith J.S.; Manne S.; Putra M.R.; Choudhary S.; Massey N.; Luo D.; Berg C.A.; Acharya S.; Sharma S.; Kanuri S.H.; Lange J.K.; Carlson S.A.; Off-Target drug effects resulting in altered gene expression events with epigenetic and \u201cQuasi-Epigenetic\u201d origins. Pharmacol Res 2016,107,229-233","journal-title":"Pharmacol Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.yebeh.2003.11.008","volume":"5","author":"Ortinski P.","year":"2004","unstructured":"Ortinski P.; Meador K.J.; Cognitive side effects of antiepileptic drugs. Epilepsy Behav 2004,5(Suppl. 1),S60-S65","journal-title":"Epilepsy Behav"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1535759718822032","volume":"19","author":"Barr W.B.","year":"2019","unstructured":"Barr W.B.; Understanding the cognitive side effects of antiepileptic drugs: Can functional imaging be helpful? Epilepsy Curr 2019,19(1),22-23","journal-title":"Epilepsy Curr"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/175517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:51:51Z","timestamp":1582293111000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/175517\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,23]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x17666191010094849","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}